Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

  • Principal Investigator: Stephanie Gillibrand
  • 1 October 2022 to 30 September 2023
  • Project No: 611
  • Funding round: FR5

Background: There are clear differences in cervical screening attendance for different groups according to factors such as health, income, ethnicity and age. Previous research looking into barriers to screening for underserved and marginalised groups, has focused on barriers specific to the routine method of healthcare practitioner taken cervical samples (i.e. the “smear” test). Many of the barriers to screening link closely to the cervical sampling method of screening and therefore this has been a focus of research in this space. Recent developments on the potential use of self-sampling methods for cervical screening, including vaginal and urine sampling provide a potentially less intrusive method. However, research is needed to explore how this may address inequalities in screening uptake for different groups.

Aims:

To understand experiences during and barriers to cervical screening

To explore views of individuals eligible for screening and key healthcare staff towards self-sampling as alternative screening methods and how this may a) address existing barriers to screening and b) impact any changes in screening within primary care service delivery.

Design & method

We will use semi-structured interviews and focus groups with under-screened groups, including younger women and those with health conditions, as well as primary care staff. We aim to recruit up to 35 members of the public and between 5-10 health-care professionals across Greater Manchester. GP practices with the lowest screening levels will be identified by analysing an existing database. Some of these practises will be used to recruit patients for the interviews and staff for the interviews and focus groups.

Patient and public involvement

• We will work with community members within areas of Greater Manchester where uptake is low in order to work together on the research plans, to help us to design appropriate information for study participants. We will also work together to analyse, present and write about the findings.

Reporting our findings

• We will discuss our findings with healthcare staff and our community partners and will work together to present findings in ways that are inclusive and easy to understand. We will also write up our findings for articles to be presented in research journals. We will also link with local decision makers via connections to Health Innovation Manchester and Policy @ Manchester, so the findings can inform screening policy and practice in the region. We will also use the findings to develop a larger scale study that could provide further evidence to inform how screening is done nationally.

Amount Awarded: £49,996

Projects by themes

We have grouped projects under the five SPCR themes in this document

Evidence synthesis working group

The collaboration will be conducting 18 high impact systematic reviews, under four workstreams.